Synaptotagmin IV (Syt IV) is a member of the synaptotagmin family, which are synaptic vesicle membrane proteins thought to be involved in the regulation of neurotransmitter release. Unlike other synaptotagmins, Syt IV does not bind calcium in the same way and is implicated in the regulation of synaptic plasticity rather than fast neurotransmitter release. Identifying direct chemical activators is challenging, as such interactions are typically defined for enzymes or receptors. Nevertheless, small molecules could potentially modulate the expression levels or the localization of Syt IV, thereby indirectly affecting its function. The chemical class termed Synaptotagmin IV (Syt IV) Activators represents a unique set of compounds designed to modulate cellular processes through the activation of the Synaptotagmin IV protein. Synaptotagmins are a family of transmembrane proteins primarily implicated in regulating membrane trafficking and exocytosis in neurons. Syt IV, a member of this family, is known to play a role in synaptic vesicle trafficking and neurotransmitter release.
The methods employed by Syt IV Activators are intricately linked to their structural features. These activators typically harbor specific chemical motifs that enable selective binding to Syt IV, promoting a targeted and efficient response. The specificity of this interaction is crucial for the precise modulation of Syt IV's regulatory activity in membrane trafficking events. Advanced structural techniques, such as X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy, can be employed to unravel the details of the binding sites and conformational alterations induced by Syt IV Activators. Understanding these molecular intricacies not only enhances our knowledge of Syt IV activation but also contributes to a broader understanding of cellular processes related to synaptic transmission, vesicle dynamics, and the regulation of essential pathways involved in neuronal communication.
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA可激活蛋白激酶C(PKC),后者可磷酸化蛋白并改变其功能或定位。这可能会调节突触囊泡中Syt IV的运输或功能。 | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
作为一种能增加 cAMP 的腺苷酸环化酶激活剂,福斯可林可能会影响突触蛋白的表达和可塑性,进而影响 Syt IV 在突触过程中的作用。 | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
通过破坏蛋白质从内质网到高尔基体的转运,布雷费丹 A 可能会影响 Syt IV 的加工和转运,从而影响其定位和功能。 | ||||||
K-252a | 99533-80-9 | sc-200517 sc-200517B sc-200517A | 100 µg 500 µg 1 mg | $126.00 $210.00 $488.00 | 19 | |
作为一种广谱激酶抑制剂,K252a 可影响一系列信号通路,并有可能改变包括 Syt IV 在内的突触蛋白的磷酸化状态和功能。 | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
这种化合物是蛋白磷酸酶 1 和 2A 的强效抑制剂,可导致蛋白质过度磷酸化,并可能影响 Syt IV 在突触可塑性中的作用。 | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
Nocodazole 会破坏微管,影响细胞运输机制,从而可能影响 Syt IV 向突触部位的输送。 | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $260.00 $799.00 | 36 | |
肌动蛋白聚合抑制剂可能会影响细胞骨架动力学,从而影响突触蛋白(如 Syt IV)的贩运和定位。 | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
众所周知,锂会影响几种信号通路,包括涉及糖原合酶激酶 3(GSK-3)的信号通路,这可能会影响突触蛋白的表达和功能。 | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $28.00 $88.00 $332.00 | 12 | |
作为HMG-CoA还原酶的抑制剂,洛伐他汀可以影响胆固醇的合成,从而间接影响神经元的膜动力学和蛋白质运输,并因此可能影响Syt IV的功能。 | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
视黄酸可调节基因表达,并已被证明可影响神经可塑性和突触的形成,这可能涉及对 Syt IV 水平或功能的调节。 |